Recordati SpA said it acquired three of Bayer AG's consumer health brands in the French market.
The Italian company bought Transipeg and TransipegLib, laxatives for treating symptomatic constipation in adults, and Colopeg, a large volume bowel cleanser indicated in preparation for endoscopic exploration.
The products had net sales of about €10 million in France in 2016.
